Grossman William — SEC insider filings

SEC reporting owner CIK 1730229. 14 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2020-10-05 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Arcus Biosciences, Inc. (RCUS)Chief Medical Officer6—6 legs · 15,442 sh · $439,3384
enGene Therapeutics Inc. (ENGN)Interim Chief Medical Officer, Director31 leg · 5,102 sh · $10,051—3
Day One Biopharmaceuticals, Inc. (DAWN)Director5——12

Insider filings — Grossman William

FiledFormIssuerReported transactionsSource
2026-09-244enGene Therapeutics Inc. (ENGN)Purchase (P): 5,102 @ $1.97EDGAR
2026-06-174enGene Therapeutics Inc. (ENGN)Grant/award (A): 31,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2026-04-234Day One Biopharmaceuticals, Inc. (DAWN)Disposition to issuer (D): 66,660 (derivative) · Disposition to issuer (D): 32,335 (derivative) · Disposition to issuer (D): 22,500 (derivative) · Disposition to issuer (D): 15,000 (derivative)EDGAR
2025-11-074Day One Biopharmaceuticals, Inc. (DAWN)Disposition to issuer (D): 66,660 (derivative) @ $0 · Grant/award (A): 66,660 (derivative) @ $0 · Disposition to issuer (D): 32,335 (derivative) @ $0 · Grant/award (A): 32,335 (derivative) @ $0EDGAR
2025-07-104enGene Holdings Inc. (ENGN)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2025-06-044Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-05-284Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 32,335 (derivative) @ $0EDGAR
2024-01-194Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 66,660 (derivative) @ $0EDGAR
2021-06-214Arcus Biosciences, Inc. (RCUS)Sale (S): 3,047 @ $24.13 · Sale (S): 127 @ $24.77 · Sale (S): 3,891 @ $23.68EDGAR
2021-04-264Arcus Biosciences, Inc. (RCUS)Sale (S): 4,133 @ $31.37EDGAR
2021-03-184Arcus Biosciences, Inc. (RCUS)Sale (S): 2,127 @ $35.03EDGAR
2021-01-204Arcus Biosciences, Inc. (RCUS)Grant/award (A): 18,750 @ $0 · Grant/award (A): 112,500 (derivative) @ $0EDGAR
2020-12-184Arcus Biosciences, Inc. (RCUS)Sale (S): 2,117 @ $31.35EDGAR
2020-10-054Arcus Biosciences, Inc. (RCUS)Grant/award (A): 100,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $17EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1730229 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs